Inventor
Jerald C. Sadoff
Inventor
Washington, DC, US
Overview
Patents· 30 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes29%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations20%
Y02ATechnologies for adaptation to climate change16%
C12NMicroorganisms or enzymes15%
C07KPeptides12%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
C07HSugars1%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
8,771,709'Therapeutic vaccination against active Tuberculosis'20148,728,492'Malaria vaccine compositions and constituents which elicit cell mediated immunity'20148,658,136'Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response'20148,609,402'Multivalent vaccines comprising recombinant viral vectors'20138,414,884'Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response'20138,361,482'Recombinant BCG tuberculosis vaccine designed to elicit immune responses to mycobacterium tuberculosis in all physiological stages of infection and disease'20138,202,723'Multivalent vaccines comprising recombinant viral vectors'20128,053,568'Bacterial packaging strains useful for generation and production of recombinant double-stranded RNA nucleocapsids and uses thereof'20118,043,857'Recombinant BCG strains with enhanced ability to escape the endosome'20118,012,467'Multivalent vaccines comprising recombinant viral vectors'20117,935,354'Generation of new BCG vaccine strains protecting against the establishment of latent Mycobacterium tuberculosis infection and reactivation from the latent or persistent state'20117,883,696'Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response'20117,829,104'Electroporation of Mycobacterium and overexpression of antigens in mycobacteria'20107,670,609'Recombinant BCG tuberculosis vaccine designed to elicit immune responses to Mycobacterium tuberculosis in all physiological stages of infection and disease'20107,666,656'Recombinant BCG strains with enhanced ability to escape the endosome'20107,625,572'Transformed bacterium lacking selectable marker and overexpression of antigens in mycobacteria'20097,608,256'Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response'20097,235,234'Bacterial delivery system'20077,235,644'Vaccine against Gram-negative bacterial infections'20077,045,336'Bacterial delivery system'20067,025,963'Vaccine against Gram-negative bacterial infections'20067,018,636'Vaccine against Gram-negative bacterial infections'20066,902,743'Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix'20056,872,398'Conjugate vaccine against gram-negative bacterial infections'20056,531,313'Invasive bacterial vectors for expressing alphavirus replicons'20036,410,012'Antimicrobial mediated bacterial DNA delivery'20026,315,999'Pharmaceutical product for the treatment of sepsis'20016,224,880'Immunization against Streptococcus pneumoniae using conjugated and unconjugated pneumoccocal polysaccharide vaccines'20015,824,538'Shigella vector for delivering DNA to a mammalian cell'19984,285,936'Method for producing a vaccine against bacterial infections caused by pseudomonas aeruginosa'1981Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1981–2007Patents assigned to US ARMY (10)· patent assignee history
1981–2014Based in Washington, DC, US· patent location history
2003Based in Bluebell, PA, US· patent location history
2009–2014Patents assigned to AERAS GLOBAL TB VACCINE FOUND (11)· patent assignee history
2011Patents assigned to AERAS GLOBAL TB VACCINE FOUNDATION (5)· patent assignee history
2011–2014Patents assigned to CRUCELL HOLLAND BV (4)· patent assignee history
2011Based in Rockville, MD, US· patent location history
2012–2014Patents assigned to SADOFF JERALD C (5)· patent assignee history
2012–2013Based in Bethesda, MD, US· patent location history
2014Based in Amsterdam, NL· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AERAS GLOBAL TB VACCINE FOUND | 11 | 2009–2014 |
| US ARMY | 10 | 1981–2007 |
| AERAS GLOBAL TB VACCINE FOUNDATION | 5 | 2011 |
| SADOFF JERALD Cself | 5 | 2012–2014 |
| CRUCELL HOLLAND BV | 4 | 2011–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Washington, DC, US | 25 | 1981–2014 |
| Bethesda, Maryland, US | 2 | 2012–2013 |
| Amsterdam, NL | 1 | 2014 |
| Rockville, Maryland, US | 1 | 2011 |
| Bluebell, Pennsylvania, US | 1 | 2003 |